Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

A bariatric doctor specializes in weight-loss surgery and obesity management. These specialists perform procedures such as gastric bypass, sleeve gastrectomy, and lap band surgery. To find a qualified bariatric doctor near you, consult your healthcare provider or search for local bariatric clinics.

After sleeve gastrectomy, patients follow a specific diet to help the stomach heal and ensure success in weight loss. The diet starts with liquids, followed by pureed foods, and eventually soft foods before transitioning to solid foods. High-protein, low-fat, and low-sugar meals are critical, along with small, frequent portions.

An abdominal tumor is any abnormal growth located within the abdomen. Tumors can originate from the stomach, intestines, liver, or other abdominal organs. They can be benign or malignant, and treatment often involves surgery, chemotherapy, or radiation therapy, depending on the tumor's size, type, and stage.

The Allurion Balloon is not yet widely available on the NHS, though some private clinics in the UK offer it. This non-invasive procedure is an attractive option for individuals seeking a temporary weight-loss solution without the risks associated with surgery.

A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

Weight lost refers to the reduction in body weight that is typically achieved through lifestyle changes, medications, or bariatric surgeries like the RNY or gastric band. Weight loss, particularly significant or rapid weight loss, can have dramatic positive effects on a person's overall health, reducing the risk of heart disease, diabetes, and other obesity-related conditions. Successful weight loss usually requires long-term changes to diet, exercise, and behavior.

Gastritis erythema refers to redness or inflammation of the stomach lining, often seen during endoscopic examinations. It can indicate mild gastritis or early stages of stomach irritation. The cause may be related to infections, medication use, or diet, and treatment typically involves addressing the underlying issue.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

The lap band and sleeve gastrectomy are two different bariatric surgeries. The lap band is adjustable and reversible, involving the placement of a band around the upper stomach. The sleeve, on the other hand, is permanent and involves the removal of part of the stomach. Sleeve gastrectomy tends to offer more substantial long-term weight loss, but the lap band has fewer immediate risks.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.